Cytokinetics Inc (CYTK)
64.40
-2.42
(-3.62%)
USD |
NASDAQ |
Apr 25, 10:44
Cytokinetics Total Long Term Debt (Quarterly): 617.45M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 617.45M |
September 30, 2023 | 609.02M |
June 30, 2023 | 609.78M |
March 31, 2023 | 610.62M |
December 31, 2022 | 610.58M |
September 30, 2022 | 608.53M |
June 30, 2022 | 197.02M |
March 31, 2022 | 195.68M |
December 31, 2021 | 142.84M |
September 30, 2021 | 140.96M |
June 30, 2021 | 139.14M |
March 31, 2021 | 137.39M |
December 31, 2020 | 135.71M |
September 30, 2020 | 134.02M |
June 30, 2020 | 132.37M |
March 31, 2020 | 130.80M |
December 31, 2019 | 129.26M |
September 30, 2019 | 44.76M |
June 30, 2019 | 44.47M |
March 31, 2019 | 42.59M |
December 31, 2018 | 42.41M |
September 30, 2018 | 41.90M |
June 30, 2018 | 32.36M |
March 31, 2018 | 31.95M |
December 31, 2017 | 31.78M |
Date | Value |
---|---|
September 30, 2017 | 30.30M |
June 30, 2017 | 30.16M |
March 31, 2017 | 30.02M |
December 31, 2016 | 29.88M |
September 30, 2016 | 29.74M |
June 30, 2016 | 29.60M |
March 31, 2016 | 29.47M |
December 31, 2015 | 14.64M |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.152M |
September 30, 2011 | 0.31M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
44.47M
Minimum
Jun 2019
617.45M
Maximum
Dec 2023
282.65M
Average
140.96M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
Johnson & Johnson | 0.00 |
Eli Lilly and Co | 25.23B |
Viking Therapeutics Inc | -- |
Madrigal Pharmaceuticals Inc | -- |